Isolation conditions immunomodulatory and anti-inflammatory activites of rice bran feruloylated oligosaccharides

碩士 === 中華醫事科技大學 === 生物科技研究所 === 96 === This study was to investigate the optimization conditions of feruloylated oligosaccharides preparation from rice bran by acid hydrolysis and to evaluate the immunomodulatory function of feruloylated oligosaccharides. To obtain the optimization conditions of fer...

Full description

Bibliographic Details
Main Authors: Yi-Ting Fang, 方怡婷
Other Authors: Hua-Han Chen
Format: Others
Language:zh-TW
Published: 2009
Online Access:http://ndltd.ncl.edu.tw/handle/78511314853398292418
id ndltd-TW-097HWAI7111019
record_format oai_dc
spelling ndltd-TW-097HWAI71110192015-11-20T04:22:40Z http://ndltd.ncl.edu.tw/handle/78511314853398292418 Isolation conditions immunomodulatory and anti-inflammatory activites of rice bran feruloylated oligosaccharides 米糠阿魏酸寡醣純化條件及其免疫調節ˋ抗發炎活性之評估 Yi-Ting Fang 方怡婷 碩士 中華醫事科技大學 生物科技研究所 96 This study was to investigate the optimization conditions of feruloylated oligosaccharides preparation from rice bran by acid hydrolysis and to evaluate the immunomodulatory function of feruloylated oligosaccharides. To obtain the optimization conditions of feruloylated oligosaccharides preparation, response surface methodology (RSM) was introduced in this study. The optimal condition of 193 mM of TFA and 1.36 h of hydrolysis time was derived from canonical analysis. 2.2% of feruloylated oligosaccharides recovery was verified from predicted optimal condition and confirmed the fitness and applicability of this model. The immunomodulatory activity of feruloylated oligosaccharides was evaluated through RAW264.7 macrophage cells model. Inflammatory mediators, including the nitric oxide (NO), tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), interleukin-6 (IL-6) and prostaglandins E2 (PGE2) were surveyed separately. The results showed that the increasing of NO releasing and TNF-α, IL-1β, IL-6 and PGE2 secretion were in proportion to the increasing concentrations of feruloylated oligosaccharides. Furthermore, inflammation-prevent model (Model A) and inflammation-repairing model (Model B) of feruloylated oligosaccharides were both investigated to clarify anti-inflammatory activity in the LPS-induced RAW264.7 macrophage cells model. The data from model A and model B revealed that feruloylated oligosaccharides could significantly reduce the LPS-induced NO secretion and increased IL-10 production, but inhibited pro-inflammatory cytokine and PGE2 production. Therefore, feruloylated oligosaccharides could reveal the immunomodulatory activity. In addition, it also had the inflammation-prevent and inflammation-repair abilities against LPS-induced inflammatory effect. Hua-Han Chen 陳樺翰 2009 學位論文 ; thesis 100 zh-TW
collection NDLTD
language zh-TW
format Others
sources NDLTD
description 碩士 === 中華醫事科技大學 === 生物科技研究所 === 96 === This study was to investigate the optimization conditions of feruloylated oligosaccharides preparation from rice bran by acid hydrolysis and to evaluate the immunomodulatory function of feruloylated oligosaccharides. To obtain the optimization conditions of feruloylated oligosaccharides preparation, response surface methodology (RSM) was introduced in this study. The optimal condition of 193 mM of TFA and 1.36 h of hydrolysis time was derived from canonical analysis. 2.2% of feruloylated oligosaccharides recovery was verified from predicted optimal condition and confirmed the fitness and applicability of this model. The immunomodulatory activity of feruloylated oligosaccharides was evaluated through RAW264.7 macrophage cells model. Inflammatory mediators, including the nitric oxide (NO), tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), interleukin-6 (IL-6) and prostaglandins E2 (PGE2) were surveyed separately. The results showed that the increasing of NO releasing and TNF-α, IL-1β, IL-6 and PGE2 secretion were in proportion to the increasing concentrations of feruloylated oligosaccharides. Furthermore, inflammation-prevent model (Model A) and inflammation-repairing model (Model B) of feruloylated oligosaccharides were both investigated to clarify anti-inflammatory activity in the LPS-induced RAW264.7 macrophage cells model. The data from model A and model B revealed that feruloylated oligosaccharides could significantly reduce the LPS-induced NO secretion and increased IL-10 production, but inhibited pro-inflammatory cytokine and PGE2 production. Therefore, feruloylated oligosaccharides could reveal the immunomodulatory activity. In addition, it also had the inflammation-prevent and inflammation-repair abilities against LPS-induced inflammatory effect.
author2 Hua-Han Chen
author_facet Hua-Han Chen
Yi-Ting Fang
方怡婷
author Yi-Ting Fang
方怡婷
spellingShingle Yi-Ting Fang
方怡婷
Isolation conditions immunomodulatory and anti-inflammatory activites of rice bran feruloylated oligosaccharides
author_sort Yi-Ting Fang
title Isolation conditions immunomodulatory and anti-inflammatory activites of rice bran feruloylated oligosaccharides
title_short Isolation conditions immunomodulatory and anti-inflammatory activites of rice bran feruloylated oligosaccharides
title_full Isolation conditions immunomodulatory and anti-inflammatory activites of rice bran feruloylated oligosaccharides
title_fullStr Isolation conditions immunomodulatory and anti-inflammatory activites of rice bran feruloylated oligosaccharides
title_full_unstemmed Isolation conditions immunomodulatory and anti-inflammatory activites of rice bran feruloylated oligosaccharides
title_sort isolation conditions immunomodulatory and anti-inflammatory activites of rice bran feruloylated oligosaccharides
publishDate 2009
url http://ndltd.ncl.edu.tw/handle/78511314853398292418
work_keys_str_mv AT yitingfang isolationconditionsimmunomodulatoryandantiinflammatoryactivitesofricebranferuloylatedoligosaccharides
AT fāngyítíng isolationconditionsimmunomodulatoryandantiinflammatoryactivitesofricebranferuloylatedoligosaccharides
AT yitingfang mǐkāngāwèisuānguǎtángchúnhuàtiáojiànjíqímiǎnyìdiàojiéˋkàngfāyánhuóxìngzhīpínggū
AT fāngyítíng mǐkāngāwèisuānguǎtángchúnhuàtiáojiànjíqímiǎnyìdiàojiéˋkàngfāyánhuóxìngzhīpínggū
_version_ 1718133193862807552